Peer Review History
Original SubmissionApril 28, 2024 |
---|
PONE-D-24-15143Predicting early cessation of exclusive breastfeeding using machine learning techniquesPLOS ONE Dear Dr. Nejsum, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Sep 14 2024 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Astrid M. Kamperman Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please note that PLOS ONE has specific guidelines on code sharing for submissions in which author-generated code underpins the findings in the manuscript. In these cases, all author-generated code must be made available without restrictions upon publication of the work. Please review our guidelines at https://journals.plos.org/plosone/s/materials-and-software-sharing#loc-sharing-code and ensure that your code is shared in a way that follows best practice and facilitates reproducibility and reuse. 3. For studies involving third-party data, we encourage authors to share any data specific to their analyses that they can legally distribute. PLOS recognizes, however, that authors may be using third-party data they do not have the rights to share. When third-party data cannot be publicly shared, authors must provide all information necessary for interested researchers to apply to gain access to the data. (https://journals.plos.org/plosone/s/data-availability#loc-acceptable-data-access-restrictions) For any third-party data that the authors cannot legally distribute, they should include the following information in their Data Availability Statement upon submission: a) A description of the data set and the third-party source b) If applicable, verification of permission to use the data set c) Confirmation of whether the authors received any special privileges in accessing the data that other researchers would not have d) All necessary contact information others would need to apply to gain access to the data [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: No Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No Reviewer #2: No ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors present results from a predictive model trained on a very impressive dataset. I point out some directions in which the manuscript and the methodology used within could benefit from a revisit. 1. The authors talk in the introduction about statistics and guidelines from the WHO that mention 6-months cessation. The outcome of interest in the current study is cessation after 1 month. Are the mothers that stop breast feeding less than a month after delivery the same as those that stop just under 6 months? Both would technically fall under the 6 month recommendation, yet intuitively I would think they would be very different groups of people with very different reasons for stopping. Could the authors provide further information to bridge their research question of 1 month cessation to the literature and guidelines of 6 month cessation? 2. Why does the observational period cover 2 years (2014 – 2015)? Naturally, adding more years would produce a sample so big that computation time might become an inconvenience. That is fine, but could the authors add a description of their rationale for this cut-off 3. Relatedly, instead of validating the models on folds from 2014/2015, it would be a lot more convincing to test how accurate predictions are on later years. That would be strong evidence the models generalize beyond the time frame under study. 4. Later in the methods, the authors state they use cross-validation to check the final performance of the model. It does not seem the authors held out part of the data exclusively for testing? It’s okay to use the same data to train and test models using cross-validation when tuning hyperparameters. For the final test, however, there should be a holdout dataset that has not been used at all in the training process. This is the only fair test of performance. See the point above for an idea to use later year(s) as the testing data. 5. Why did the authors choose random forest specifically instead of testing several algorithms against each other? There are alternatives that could generate improvements in prediction, including a boosted random forest for example or an ensemble of several models even 6. The stated aim of the paper is to create prediction models. Yet an algorithm that creates causal DAGs is used. The figure presented is visually striking, yet I would not include it in this manuscript. Causal inference requires careful consideration of which variables to include in a model and the structural relationships between these variables. The amount of variables included in the current paper are appropriate for prediction, but for causal inference they are likely to produce very biased associations. I would stick to prediction for these results 7. I would not report on p-values in Table 1. The huge sample size guarantees that trivially small differences will result in significant differences, making p-values practically uninformative. 8. Recent guidelines on publishing predictive models require some information on how the model would be implemented in the real world. Who would be doing the monitoring, how would the results be communicated and to whom? I would devote some text either in the introduction or the discussion thinking through the hows and whys of implementing this model regardless of whether it successfully predicts or not. Reviewer #2: Major points 1. What are the potential risks of using outdated data (2014 and 2015)? 2. An explanation for the choice of the 35-week gestational age cutoff should be provided. 3. For the calculus of the birth weight outliers, it would be useful if the authors provided the mean and standard deviation of birth weight in this study (lines 96-98). 4. The study criteria to construct the outcome considered the use of a maximum of one formula feeding per week after hospital discharge (lines 101-103). The authors could report the numbers of infants who were exclusively breastfed, considering the groups with and without formula feeding. 5. What is the periodicity of free home visits in the first month of a child? 6. I suggested that the authors explain how many children did not have a record of cessation of exclusive breastfeeding within the first month after birth (lines 111-113), and if it includes those who did not initiate exclusive breastfeeding. 7. The birthplace is an important variable in the findings, but the healthcare regions A-E are not completely clear to a reader from the other countries. It is suggested that the authors characterize these regions in the methods section, mainly by the socioeconomic aspects. 8. Since the authors use a multiple imputation method, what was the percentage of missing data? 9. It is suggested that authors add a reference or more explanation about Rubin’s rule (line 150) and PC-algorithm (e.g. Peter-Clark algorithm) (line 154). 10. Authors mention that the lower sparsity levels result in the strongest pathways. However, the methods section did not include an explanation of how the sparsity levels are chosen (lines 157-159). Maybe the sentence in the results section (“Since there is no golden standard method to determine the optimal sparsity level, we chose … three sparsity levels”, lines 217-218) could be moved to the methods section. 11. It is suggested that the authors add subtitles in the methods section according to the statistical analysis step (e.g. causal analysis, prediction, and validation) to help the reader. 12. Table 1 provided p-values, but the statistical test and significance level are not included in the methods section. 13. The text about Table 1 (Table 1 shows…one month, lines 205-207) only cited some associations. How are criteria used to consider the differences between the groups with and without cessation of exclusive breastfeeding? Moreover, it is important to note that p-values can be less informative in decision-making with big data, especially due to the large sample size. 14. The authors used three sparcity levels in the results section, but they chose the 10-185 level. What is the difference between them according to the DAGs and the relation of variables with breastfeeding cessation, and why does it seem the better sparcity level? 15. The explanation about the multiple imputation is before the prediction models, but if I understand it is used during prediction modeling. 16. The feature importance could be described in the methods section in the same order as the results section. 17. The authors could explore the reasons why other studies had higher AUCs, by looking beyond breastfeeding practices. It is possible that differences in the study population characteristics justified these findings (lines 314-316). 18. Although the authors did not find an important role of additional factors (21 variables) in early cessation, they could discuss the importance of these factors in other outcomes, like prolonged exclusive breastfeeding (e.g. six months). Minor points 1. Maybe the sentence “The first model included 11 well-established risk factors for cessation of... during pregnancy and delivery that potentially impede breastfeeding.” (lines 73-76) is only necessary in the methods section. 2. The first sentence of the methods section is very similar to the end of the introduction section (“In a retrospective cohort, we applied techniques from machine learning to develop and validate”, lines 79-81). I suggest that the authors specify the local and period of data in this sentence and omit the name of the analysis method (machine learning). 3. It is recommended that authors include a reference for ISCED 2011. 4. The references for the causalDisco package and the cross-validation are not shown. 5. The percentage of missing perinatal data is not 2.7% (line 196). 6. The captions could be more specific (say children) rather than use terms like study population, beyond specifying the years of study. 7. The results section has many tables and figures. The authors could reconsider their inclusions, such as Table 2 in the manuscript. 8. The resolution of the text inside the Figures is not clear. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
Revision 1 |
Predicting early cessation of exclusive breastfeeding using machine learning techniques PONE-D-24-15143R1 Dear Dr. Nejsum, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. If you have any questions relating to publication charges, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Astrid M. Kamperman Academic Editor PLOS ONE Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. If the authors have adequately addressed your comments raised in a previous round of review and you feel that this manuscript is now acceptable for publication, you may indicate that here to bypass the “Comments to the Author” section, enter your conflict of interest statement in the “Confidential to Editor” section, and submit your "Accept" recommendation. Reviewer #1: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes ********** 6. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: The authors have narrowed the focus of the manuscript to its advantage and added results based on a validation dataset. The manuscript now reads substantially better and I have more trust in the metrics reported. ********** 7. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Milan Zarchev ********** |
Formally Accepted |
PONE-D-24-15143R1 PLOS ONE Dear Dr. Nejsum, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset If revisions are needed, the production department will contact you directly to resolve them. If no revisions are needed, you will receive an email when the publication date has been set. At this time, we do not offer pre-publication proofs to authors during production of the accepted work. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few weeks to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Astrid M. Kamperman Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .